R. W. Vandivier, V. A. Fadok, P. R. Hoffmann, D. L. Bratton, C. Penvari, K. K. Brown, J. D. Brain, F. J. Accurso and P. M. Henson, “Elastase-Mediated Phosphatidylserine Receptor Cleavage Impairs Apoptotic Cell Clearance in Cystic Fibrosis and Bronchiectasis,” Journal of Clinical Investigation, Vol. 109, No. 5, 2002, pp. 661670.

has been cited by the following article:

• TITLE: Down Regulation of MyD88 in Macrophages Treated with Liposomes Composed of Phosphatidylserine

  AUTHORS: Yuka Takasugi, Futoshi Kurai, Issei Kazume, Masaki Otsuka, Yoichi Negishi, Rui Tada, Yukihiko Aramaki

  KEYWORDS: Phosphatidylserine; Liposome; MyD88; TGF-β; Macrophage

  JOURNAL NAME: Pharmacology & Pharmacy, Vol.4 No.2, April 28, 2013

  ABSTRACT: We have recently demonstrated that liposomes composed of phosphatidylserine (PS-liposomes) suppressed nitric oxide and inflammatory cytokine productions following LPS stimulation in macrophages. In this study, we examined the effect of PS-liposomes on expressions of TLR-4 and MyD88, which are essential for the signal transduction in LPS stimulation. Expression of MyD88 was suppressed when macrophages were treated with PS-liposomes, but not with liposomes of phosphatidylcholine. No change in TLR-4 expression was observed. MyD88 suppression was restored to the control levels when cells were pre-treated with anti-TGF-β antibody, suggesting that TGF-β plays an important role in down-regulation of MyD88 following PS-liposome treatment.